Pathological Background and Clinical Procedures in Oral Surgery Haemostasis Disorders: A Narrative Review
Source abstract
Abstract
Haemostasis disorders are serious pathologies that could put dental and surgical procedures at risk as they are associated with postoperative bleeding, which in some circumstances could be prolonged and dangerous for the patient. In-depth knowledge of the problems associated with coagulation pathologies and the suitable specific procedures should be implemented in dental practice. A good awareness of the clinical protocols to be used in these circumstances may help reduce operator stress and increase patient compliance. Collaboration with the haematologist is always recommended to establish an adequate treatment plan, both regarding the administration of therapies that promote haemostasis and for assessing the operative risk. Hereby, we summarize the congenital and hereditary pathologies that lead to haemostasis disorders, which can be found in patients undergoing dental procedures. The purpose of this narrative review is to frame the diseases from a clinical, anamnestic, and etiopathological standpoint, as well as to evaluate an operative approach to the pathology under consideration, with particular attention to anaesthesia manoeuvres and post-surgical haemostasis, to avoid hematoma formation and uncontrolled bleeding which can lead procedure failure up and even death. Of note, it is likewise important to educate the patient about prevention, to keep the oral cavity healthy and avoid invasive procedures, limiting the number of operative sessions.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Platelet Disorders and Treatments · Hemostasis and retained surgical items · Hemophilia Treatment and Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Surgical and Dental Sciences, University of Milan, Via Della Commenda 10, 20122 Milan, Italy
Maxillo-Facial and Odontostomatology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy
Pathology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
References (67)
Show source-provided references
1. Historical review: Megakaryopoiesis and thrombopoiesis10.1182/blood-2007-05-088500 ↗
2. Platelets: Physiology and biochemistry10.1055/s-2005-916671 ↗
3. Mechanisms of platelets aggregation10.1097/00062752-200109000-00002 ↗
4. Laino, L., Cicciù, M., Fiorillo, L., Crimi, S., Bianchi, A., Amoroso, G., Monte, I.P., Herford, A.S., and Cervino, G. (2019). Surgical Risk on Patients with Coagulopathies: Guidelines on Hemophiliac Patients for Oro-Maxillofacial Surgery. Int. J. Environ. Res. Public Health, 16.10.3390/ijerph16081386 ↗
5. Interventions for treating post-extraction bleeding
6. Management of bleeding disorders in the dental practice: Managing patients on anticoagulants10.12968/denu.2012.39.5.358 ↗
7. de Campos, N., Furlaneto, F., and De Paiva, B.Y. (2019). Contemporary Applications of Biologic Hemostatic Agents across Surgical Specialties—Volume 2, IntechOpen.
8. CD36-positive stress reticulocvtosis in sickle cell anemia10.1016/S0022-2143(96)90181-X ↗
9. Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo10.1182/blood-2006-11-056101 ↗
10. Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: Role in adhesion of sickle red blood cells to endothelial cells10.1182/blood-2006-07-035139 ↗
11. Deconstructing sickle cell disease: A reappraisal of the role of hemolysis in the development of clinical subphenotypes10.1016/j.blre.2006.07.001 ↗
12. A novel molecular basis for beta thalassemia intermedia poses new questions about its pathophysiology10.1182/blood-2005-02-0593 ↗
13. Paroxysmal nocturnal hemoglobinuria: An acquired X-linked genetic disease with somatic-cell inosaicism10.1016/j.gde.2006.04.015 ↗
14. Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria10.1111/j.1365-2141.2007.06554.x ↗
15. Management of cold haemolytic syndrome10.1111/j.1365-2141.2007.06664.x ↗
16. Treatment of autoimmune hemolytic anemia10.1053/j.seminhematol.2005.04.003 ↗
17. NALP1 in vitiligo-associated multiple autoimmune disease10.1056/NEJMoa061592 ↗
18. Iron homeostasis10.1146/annurev.physiol.69.031905.164337 ↗
19. Anemia of inflammation: The hepcidin link10.1097/00062752-200503000-00001 ↗
20. Current concepts in the pathophysiology and treatment of aplastic anemia10.1182/blood-2006-03-010777 ↗
21. Molecular pathogenesis of Fanconi anemia: Recent progress10.1182/blood-2005-10-4240 ↗
22. The 2017 International Classification of the Ehlers-Danlos Syndromes10.1002/ajmg.c.31552 ↗
23. Caliogna, L., Guerrieri, V., Annunziata, S., Bina, V., Brancato, A.M., Castelli, A., Jannelli, E., Ivone, A., Grassi, F.A., and Mosconi, M. (2021). Biomarkers for Ehlers-Danlos Syndromes: There Is a Role?. Int. J. Mol. Sci., 22.10.3390/ijms221810149 ↗
24. Local anaesthetic failure in joint hypermobility syndrome10.1177/014107680509800222 ↗
25. Insufficient effect of local analgesics in Ehlers Danlos type III patients (connective tissue disorder)10.1111/j.1399-6576.1990.tb03103.x ↗
26. Anaesthesia recommendations for patients suffering from Ehlers-Danlos syndrome
27. Future treatments for hereditary hemorrhagic telangiectasia10.1186/s13023-019-1281-4 ↗
28. Snodgrass, R.O., Chico, T.J.A., and Arthur, H.M. (2021). Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions. Genes, 12.10.3390/genes12020174 ↗
29. Hereditary haemorrhagic telangiectasia10.1111/j.1365-2516.2008.01774.x ↗
30. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): A view from the 21st century10.1136/pmj.79.927.18 ↗
31. Pathogenesis of thrombotic microangiopathies10.1146/annurev.pathmechdis.3.121806.154311 ↗
32. Genetic defects leading to hereditary thrombotic thrombocytopenic purpura10.1053/j.seminhematol.2003.10.002 ↗
33. The molecular biology ofthrombotic microangiopathy10.1038/sj.ki.5001535 ↗
34. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology10.1182/blood.V88.1.3.3 ↗
35. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: A prospective study of a population-based cohort of 245 patients10.1046/j.1365-2141.2003.04547.x ↗
36. Immune thrombocytopenia (ITP)
37. Long-term outcomes in adults with chronic ITP after splenectomy failure10.1182/blood-2003-11-3908 ↗
38. Multi-dysfunctional pathophysiology in ITP10.1016/j.critrevonc.2004.12.004 ↗
39. Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update10.1053/tmrv.2003.50004 ↗
40. Pathogenesis in immune thrombocytopenia: New insights. American Society of Hematology10.1182/asheducation.V2012.1.306.3798320 ↗
41. Immune thrombocytopenic purpura—The changing therapeutic landscape10.1056/NEJMp068169 ↗
42. Glanzmann thrombasthenia10.1186/1750-1172-1-10 ↗
43. Thrombocytoasthenia and thrombocytopathia. Old names and new diseases10.1182/blood.V11.11.965.965 ↗
44. Glanzmann’s thrombasthenia. I. Congenital bleeding disorders with long bleeding time and normal platelet count10.1016/0002-9343(66)90003-9 ↗
45. Glanzmann’s thrombasthenia: The spectrum of clinical disease10.1182/blood.V75.7.1383.1383 ↗
46. Glanzmann thrombasthenia: An update10.1016/j.cca.2009.10.016 ↗
47. Dental treatment of patients with coagulation factor alterations: An update
48. Dental management of patients receiving anticoagulant and/or antiplatelet treatment
49. Is alteration in single drug anticoagulant/antiplatelet regimen necessary in patients who need minor oral surgery? A systematic review with meta-analysis10.1007/s00784-021-03882-z ↗
50. WFH Guidelines for the Management of Hemophilia, 3rd edition10.1111/hae.14046 ↗
51. Orofacial manifestations of hematological disorders: Anemia and hemostatic disorders10.4103/0970-9290.87070 ↗
52. Hemophilia: What the Oral and Maxillofacial Surgeon Needs to Know10.1016/j.coms.2016.06.006 ↗
53. Proposal of a standard approach to dental extraction in haemophilia patients. A case-control study with good results10.1046/j.1365-2516.2000.00423.x ↗
54. Inherited, congenital and acquired disorders by hemostasis (vascular, platelet and plasmatic phases) with repercussions in the therapeutic oral sphere
55. Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor10.1111/j.1538-7836.2006.02146.x ↗
56. What does the Cochrane database of systematic reviews tell us about hemophilia?10.1080/17474086.2019.1676718 ↗
57. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions
58. New therapies for hemophilia10.1182/blood-2018-08-872291 ↗
59. (2023, February 02). American Board of Internal Medicine. Available online: https://www.abim.org/Media/bfijryql/laboratory-reference-ranges.pdf.
60. Point-of-care platelet function tests: Relevance to arterial thrombosis and opportunities for improvement10.1007/s11239-020-02170-z ↗
61. Platelet Function Tests: Preanalytical Variables, Clinical Utility, Advantages, and Disadvantages10.1007/978-1-4939-7196-1_24 ↗
62. Platelet immunophenotyping in health and inherited bleeding disorders, a review and practical hints10.1002/cyto.b.21892 ↗
63. Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel10.1016/j.jacc.2020.06.085 ↗
64. Coagulopathy management of multiple injured patients—A comprehensive literature review of the European guideline 201910.1530/EOR-22-0054 ↗
65. Bleeding disorders in implant dentistry: A narrative review and a treatment guide10.1186/s40729-022-00418-2 ↗
66. McCarty, T.S., and Ankur, D.S. (2022). Desmopressin, StatPearls.
67. Perioperative management of the bleeding patient10.1093/bja/aew358 ↗